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Abstract
Introduction: Chemokine receptors play an important role in mediating the recruitment of T cells to inflammatory
sites. Previously, small proportions of circulating Th1-type CCR5+ and Th2-type CCR3+ cells have been shown in
granulomatosis with polyangiitis (GPA). Wondering to what extent CCR4 and CCR6 expression could also be
implicated in T cell recruitment to inflamed sites in GPA, we investigated the expression of CCR4 and CCR6 on T
cells and its association with T cell diversity and polarization.
Methods: Multicolor flow cytometry was used to analyze CCR4, CCR6, and intracellular cytokine expression of T
cells from whole blood of GPA-patients (n = 26) and healthy controls (n = 20). CCR7 and CD45RA were included
for phenotypic characterization.
Results: We found a significant increase in the percentages of circulating CCR4+ and CCR6+ cells within the total CD4
+ T cell population in GPA. In contrast, there was no difference in the percentages of CD8+CCR4+ and CD8+CCR6+ T
cells between GPA and healthy controls. CCR4 and CCR6 expression was largely confined to central (TCM) and effector
memory T cells (TEM, TEMRA). A significant increase in the frequency of CCR4+ and CCR6+ TEMRA and CCR6+ TCM was
shown in GPA. Of note, we could dissect CCR4 and CCR6 expressing CCR7+CD45RAmed very early memory T cells (TVEM)
from genuine CCR7+CD45RAhigh naïve T cells lacking CCR4 and CCR6 expression for peripheral tissue-migration within
the CCR7+CD45RA+ compartment. The frequencies of CCR4+ and CCR6+ TVEM were also significantly increased in GPA.
An increased percentage of IL-17+ and IL-22+ cells was detected in the CCR6+ cell subsets and IL-4+ cells in the CRR4+
cell subset when compared with CD4+ cells lacking CCR4 and CCR6 expression.
Conclusions: Increased frequencies of circulating CCR4+ and CCR6+ memory T cell subsets including hitherto
unreported TVEM suggest persistent T cell activation with the accumulation of CCR4+ and CCR6+ cells in GPA.
CCR4 and CCR6 could be involved in the recruitment of T cells including cytokine-producing subsets to inflamed
sites in GPA.
Introduction
T cells display considerable heterogeneity in terms of
phenotype, function, and anatomical distribution.
Whereas naïve T cells represent a relatively homoge-
nous population, primed T cells acquire effector func-
tions and differentiate into distinct effector and memory
subsets. Whereas naïve and central memory T cells
home to secondary lymphoid organs to mount antigen-
driven proliferative responses, effector memory T cells
migrate into peripheral tissues to display immediate
effector functions such as cytokine production or cyto-
toxicity or both [1,2]. The process of T cell recruitment
from blood into tissue is controlled by adhesion mole-
cules, in which chemokine receptors have an important
role [2].* Correspondence: peter.lamprecht@uk-sh.de
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Previously, we showed that a small proportion of cir-
culating memory T cells displays T-helper cell 1 (Th1)-
type CC chemokine receptor (CCR) 5 and Th2-type
CCR3 expression in granulomatosis with polyangiitis
(GPA) [3]. GPA is a rare chronic inflammatory disorder
of unknown etiology and is characterized by necrotizing
granulomatosis of the upper or lower respiratory tract
or both and a systemic autoimmune vasculitis preferen-
tially affecting pulmonary and renal small vessels. The
vasculitis is associated with highly specific anti-neutro-
phil cytoplasmic autoantibodies to proteinase 3 (PR3-
ANCA) [4]. T cells are abundant in inflammatory
lesions in GPA. CCR5, CCR3, and their chemokine
ligand CCL5 (regulated upon activation in normal T
cells, expressed and secreted, or RANTES) are expressed
in granulomatous lesions of the respiratory tract. These
studies suggested that CCR5 and CCR3 could be
involved in the recruitment of interferon-gamma (IFNg)-
producing and tumor necrosis factor-alpha-producing
Th1- and interleukin (IL)-4-producing Th2-type cells to
inflammatory sites in GPA [5-7]. More recently, IL-17-
producing PR3-specific Th17 cells have been implicated
in the maintenance of chronic inflammation and auto-
immunity in GPA [8-10]. CCR4+ T cells have been
reported to secrete IL-4, whereas CCR6+ cells produce
IL-17 [11,12]. To investigate the extent to which the
chemokine receptors CCR4 and CCR6 could be impli-
cated in T-cell recruitment in GPA, we analyzed CCR4
and CCR6 expression on circulating T cells, assigned
CCR4- and CCR6-expressing cells to the respective
memory cell subsets, and determined the cytokine pro-
duction of CCR4+ and CCR6+ T cells.
Materials and methods
Study population
Patients fulfilled the American College of Rheumatology
criteria and the Chapel Hill Consensus Conference defini-
tion for GPA, respectively [13,14]. Disease activity was
recorded in accordance with European League Against
Rheumatism recommendations (Table 1) [15]. All patients
and controls provided informed consent. The study was
approved by the local ethics committee (#07-059).
Antibodies used for flow cytometry
The following antibodies were used in different combi-
nations: Pacific blue (PB)-conjugated anti-CD3, PB- or
phycoerythrin (PE)-conjugated anti-CD4, peridinin
chlorophyll protein (PerCP)- or allophycocyanine-cya-
nine dye 7 (APC-Cy7)-conjugated anti-CD8, fluorescein
isothiocyanate (FITC)-conjugated anti-CD45RA, Alexa
Fluor 647-conjugated anti-CCR7, PE-Cy7- and PE-con-
jugated anti-CCR4, PE-conjugated anti-CCR6, APC-
Cy7-conjugated anti-IFNg, PE-Cy7-conjugated anti-IL-4,
and Alexa Fluor 488-conjugated anti-IL-17a from
eBioscience (Frankfurt, Germany) and APC-conjugated
anti-IL-22 from R&D Systems (Wiesbaden, Germany).
Appropriate isotype controls were included in the
experimental setup. All antibodies (unless indicated
otherwise) were purchased from BD Biosciences (Hei-
delberg, Germany).
Surface marker and intracellular cytokine staining
Flow cytometry was performed to characterize T cell
populations at the single-cell level. Staining of cellular
surface markers was performed by using freshly col-
lected whole blood (Li-heparin) as described earlier [3].
Briefly, previously determined optimal concentrations of
fluorochrome-conjugated monoclonal antibodies for cell
surface antigens were added to 100 μL of whole blood
and incubated 45 minutes in the dark at 4°C. Subse-
quently, erythrocytes were lysed by the addition of
FACS (fluorescence-activated cell sorting) Lysing Solu-
tion (BD Pharmingen, Heidelberg, Germany). After
incubation for another 10 minutes in the dark at room
temperature, cells were washed twice with phosphate-
buffered saline/0.01% bovine serum albumin and imme-
diately analyzed by FACS.
For intracellular cytokine staining, freshly collected
whole blood was stimulated with phorbol myristate acet-
ate (Sigma, Munich, Germany) (10 ng/mL) and ionomy-
cin (Sigma) (1 μg/mL) for 4 hours at 37°C in a
humidified atmosphere with 5% CO2. Brefeldin (Sigma)
(10 μg/mL) was added at the beginning of the stimula-
tion to inhibit cytokine secretion. After staining for sur-
face antigens and lysing of erythrocytes with FACS
Lysing Solution, cells were fixed and permeabilized with
Cytofix/Cytoperm in accordance with the instructions of
the manufacturer (BD Pharmingen). Staining of intracy-
toplasmatic cytokines was performed at 4°C for 45 min-
utes in the dark with previously determined optimal
concentrations of fluorochrome-conjugated monoclonal
antibodies for cytokines or appropriate negative (isotype)
controls. Besides appropriate isotype controls, an unsti-
mulated sample was included for each patient and con-
trol as a negative control.
Flow cytometric analysis
Multicolor flow cytometric analysis was performed on a
FACS Canto II cytometer by using FACSDiva software
(BD Biosciences). Lymphocytes were gated for analysis
on the basis of light scattering properties and of CD3,
CD4, and CD8 staining. Positively and negatively stained
populations were calculated by quadrant dot plot analy-
sis determined by isotype controls.
Statistical analysis
Statistics were performed by using Prism 4.0 (GraphPad
Software, La Jolla, CA, USA). Comparisons between
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patients and control subjects were done by employing
the non-parametric Mann-Whitney U test. P values
equal to or less than 0.05 were considered to be statisti-
cally significant.
Results
Increased frequency of CCR4- and CCR6-expressing CD4+
T cells in granulomatosis with polyangiitis
To assess CCRs relevant for migration to peripheral tis-
sues, we determined the expression of the CCR4 and
CCR6 on peripheral blood T cells in patients with GPA
and healthy controls. We found a significant increase in
the percentages of CCR4- and CCR6-expressing cells
within the total CD4+ T cell population in patients with
GPA compared with healthy individuals (Figure 1a, b).
Apart from the CCR4+CCR6- and CCR4-CCR6+ ’single
positive’ subsets, a smaller fraction of CCR4+CCR6+
’double positive’ cells was detected within the CD4+ T
cell population in patients with GPA and healthy con-
trols (17.5% ± 4.8% versus 10.3% ± 0.6%, mean ± stan-
dard error of the mean, no significant difference, Mann-
Whitney U test). Conversely, the remainder of cells
within the CD4+ T-cell population were CCR4-CCR6-
’double negative’ cells. In contrast, there was no differ-
ence in the percentages of CD8+CCR4+ and CD8+CCR6
+ T cells between patients with GPA and healthy con-
trols (data not shown).
CCR4 and CCR6 are expressed on distinct memory cell
populations, including CCR7+CD45RAmed very early
memory cells
Having shown a significant increase in the frequencies
of CCR4- and CCR6-expressing CD4+ T cells in patients
with GPA, we were interested in phenotypic features of
CCR4- and CCR6-expressing CD4+ T cells next. To
assign CCR4+ and CCR6+ cells to the respective naïve
and memory cell subsets, cells were additionally stained
with fluorescent-conjugated antibodies for CD45RA and
CCR7 to allow discrimination into diverse T cell subsets
[2,16-18]. By the use of these markers, we found that
CCR4 and CCR6 expression was confined largely to the
circulating CCR7+CD45RA- central memory (TCM) and
CCR7-CD45RA- (TEM) and CCR7
-CD45RA+ (TEMRA)
effector memory cell subsets within the total CD4+ T
cell population. A significant increase in the frequency
of CCR4+ and CCR6+ cells was remarkable in the
CCR7-CD45RA+ effector memory (TEMRA) subset in
patients with GPA. A significant increase in CCR6+ cells
was also found in the CCR7+CD45RA- central memory
T-cell subset (TCM). However, significantly increased
percentages of CCR4+ and CCR6+ cells were also
detected in the CCR7+CD45RA+ population, which con-
tains naïve T cells (TN) by definition (Figure 2a, b). Dis-
secting the CCR7+CD45RA+ population with respect to
CD45RA fluorescence intensity, we detected two subsets
in the CCR7+CD45RA+ population. CCR7+CD45RAhigh
T cells generally lacked CCR4 and CCR6 expression
with the exception of three patients with GPA. In con-
trast, CCR7+CD45RAmed T cells displayed CCR4 and
CCR6 expression. We found higher frequencies of
CCR4+ and CCR6+ cells within the CCR7+CD45RAmed
T cell subset in patients with GPA compared with
healthy controls (Figure 2c, d). Thus, the CCR7
+CD45RA+ population contained genuine CCR7
+CD45RAhigh TN lacking CCR4 and CCR6 expression
and another CCR7+CD45RAmed T cell subset compris-
ing CCR4+ and CCR6+ cells. The latter was reminiscent
of so-called very early memory T cells (TVEM) [19].
Table 1 Clinical and laboratory characteristics of patients with GPA and healthy controls
Patients with GPA in remission Patients with active GPA Healthy controls
Number 12 14 20
Age in years, mean (range) 58 (38-83) 55 (27-77) 51 (21-78)
Sex, male/female 10/2 10/4 11/9
BVAS V3.0, mean (range) 0 10 (4-21)
CRP in mg/L, mean (range) 8 (1-17) 33 (1-86)
PR3-ANCA, positive/negative 9/3 14/0
Methotrexate, number 9 5
Azathioprine, number 1 0
Leflunomide, number 2 0
Cyclophosphamide, number 0 5
Prednisolone, number 12 10
Prednisolone dosage in mg 6.1 ± 0.8 11.9 ± 1.9a
No treatment 0 4
Remission was defined as BVAS V3.0 (Birmingham Vasculitis Activity Index version 3.0) of 0. Disease activity in patients either with first manifestation or relapsing
was defined as BVAS V3.0 of at least 1 (15). Prednisolone dosage is expressed as mean ± standard error of the mean. aP < 0.05 by Mann-Whitney U test. CRP, C-
reactive protein; GPA, granulomatosis with polyangiitis; PR3-ANCA, anti-neutrophil cytoplasmic autoantibodies targeting proteinase 3.
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Decreased frequency of CCR7+CD45RAhigh naïve T cells
and unreduced frequency of CCR7+CD45RAmed very early
memory T cells in granulomatosis with polyangiitis
Earlier studies have reported significantly lower percen-
tages of peripheral blood TN by using CCR7 and
CD45RO or CD45RB expression for the phenotypic
characterization of T cells in patients with GPA [20,21].
In this study, we showed a segregation of the CCR7
+CD45RA+ T cell compartment into different two sub-
sets based on CCR4 and CCR6 expression and CD45RA
fluorescence intensity. This prompted us to investigate
whether TN and TVEM frequencies were likewise
decreased within the total CD4+ T-cell population. In
line with the aforementioned earlier studies, we found a
significantly lower percentage of CCR7+CD45RAhigh TN
in patients with GPA compared with healthy controls










































































Figure 1 Increased frequencies of CD4+CCR4+ and CD4+CCR6+ T cells in patients with granulomatosis with polyangiitis (GPA).
Percentages of CCR4+ (a) and CCR6+ (b) cells within the total CD4+ T cell population in patients with GPA and healthy controls (HCs).
Percentages of positive cells were assessed by flow cytometry. Values are presented as mean ± standard error of the mean. ***P < 0.001, Mann-
Whitney U test. CCR, CC chemokine receptor.
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[20,21]. In contrast, CCR7+CD45RAmed TVEM frequen-
cies were similar in patients with GPA and healthy indi-
viduals (Figure 3).
Distinct cytokine-producing subsets within CCR4+ and
CCR6+ T-cell populations
We showed increased frequencies of circulating CCR4-
or CCR6-expressing (or both) CD4+ TCM, TEMRA, and
TVEM in patients with GPA. To investigate functional
features of CCR4+ and CCR6+ cells within the total CD4
+ T cell population, peripheral blood cells were stained
for intracellular cytokines. An IFNg+ cell fraction was
found in all CCR4+ or CCR6+ subsets or both. An
increased percentage of IL-17+ and IL-22+ cells was
detected in the CCR4-CCR6+ ’single positive’ and CCR4
+CCR6+ ’double positive’ cell fractions when compared
with the CCR4-CCR6- ’double negative’ cell subset.
Furthermore, an increased frequency of IL-4+ cells was
shown in the CCR4+CCR6- ’single positive’ cell fraction
compared with the CCR4-CCR6- ’double negative’ cell
subset in both patients with GPA and healthy controls.
CCR4-CCR6+ ’single positive’ and CCR4+CCR6+ ’double
positive’ cells differed from each other with respect to
the percentage of IFNg-producing cells, which was sig-
nificantly higher in the CCR4-CCR6+ ’single positive’
fraction (P < 0.01, Mann-Whitney U test). The CCR4-
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Figure 2 Increased percentages of CCR4+ and CCR6+ memory T cell subsets in patients with granulomatosis with polyangiitis (GPA).
Percentages of CD4+CCR4+ (a) and CD4+CCR6+ (b) T cells in the CCR7+CD45RA- central memory (TCM), CCR7
-CD45RA- effector memory (TEM),
CCR7+CD45RA+ ’naïve by definition’ (TN), and CCR7
-CD45RA+ ’revertant’ effector memory (TEMRA) populations. (c) Dissection of the CD4
+CCR7
+CD45RA+ population with regard to CD45RA fluorescence intensity into CCR7+CD45RAhigh cells representing genuine TN and CCR7
+CD45RAmed
cells reminiscent of very early memory T cells (TVEM). Percentages of CCR4
+ and CCR6+ cells in the CCR7+CD45RAmed and CCR7+CD45RAhigh
subsets are shown. (d) Representative quadrant dot-plot analysis showing segregation of the gated CD4+CCR7+CD45RA+ T cell population into
two subsets. CCR7+CD45RAmed T cells displayed CCR4 and CCR6 expression (TVEM). CCR7
+CD45RAhigh T cells lacked CCR4 and CCR6 expression
(genuine TN). Numbers in quadrants and histograms represent percentages of cells. Percentages of positive cells were assessed by flow
cytometry. Values are presented as mean ± standard error of the mean. *P < 0.05, ***P < 0.001, Mann-Whitney U test. CCR, CC chemokine
receptor; HC, healthy control.
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CCR6- ’double negative’ cell subset differed from the
other subsets in that only an IFNg+ cell fraction was
remarkable in this subset (Table 2). Less than 1% of
cells displayed intracellular co-expression of IL-17 and
IL-22 in CCR6+ cells within the total CD4+ T-cell popu-
lation (data not shown). Thus, circulating CD4+CCR4+
and CD4+CCR6+ T cell populations comprised distinct
subsets of cytokine-producing cells.
Discussion
Chemokine receptors play an important role in mediat-
ing T cell recruitment to distinct anatomical sites and
tissues [2]. Whereas the CC chemokine receptor CCR7
mediates homing of naïve (TN) and central memory
(TCM) T cells to lymph nodes, other CC and CXC
chemokine receptors (CCR/CXCR) trigger intravascular
adhesion and direct migration of effector memory T cell
subsets (CD45RA- TEM and CD45RA
+ ’reverted’ TEMRA)
into peripheral tissues for patrol and recruitment to
inflammatory sites [2,19]. Previously, cloned CCR6+ cells
from peripheral blood and inflammatory sites in Crohn’s
disease have been shown to produce IL-17. In contrast,
CCR4+ cells secrete IL-4 [11,12,22]. Recently, Th17-,
Th22-, and Th2-type PR3-specific cells have been sug-
gested to be involved in chronic inflammation and auto-
immunity in GPA [8-10,23]. Moreover, an increased
proportion of circulating CD45RClow Th2-type and
Th17 cells has been reported in ANCA-associated vas-
culitides, including GPA. The increase is independent of
disease duration and treatment [24]. Therefore, to
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Figure 3 Decreased frequency of naïve T cells (TN) and unreduced frequency of very early memory T cells (TVEM) in patients with
granulomatosis with polyangiitis (GPA). Percentages of CCR7+CD45RAmed TVEM and CCR7
+CD45RAhigh TN in the CD4
+ T cell population are
shown. Percentages of positive cells were assessed by flow cytometry. Values are presented as mean ± standard error of the mean. **P < 0.01,
Mann-Whitney U test. CCR, CC chemokine receptor; HC, healthy control.
Table 2 Percentages of cytokine-producing CCR4+ and/or CCR6+ cell subsets within the total CD4+ T cell population
compared with the CCR4-CCR6- cell subset
Granulomatosis with polyangiitis
CCR4-CCR6- cells CCR4+CCR6- cells CCR4-CCR6+ cells CCR4+CCR6+ cells
Percentage of IFNg+ cells 11.3 ± 5.1 5.5 ± 2.0 28.2 ± 4.3 4.0 ± 0.5
Percentage of IL-4+ cells 1.0 ± 0.5 5.5 ± 1.5a 0.6 ± 0.3 1.0 ± 0.4
Percentage of IL-17+ cells 0.1 ± 0.0 0.1 ± 0.0 7.8 ± 1.8a 9.5 ± 0.9b
Percentage of IL-22+ cells 0.1 ± 0.0 0.2 ± 0.1 2.4 ± 0.5a 3.4 ± 0.6a
Healthy controls
CCR4-CCR6- cells CCR4+CCR6- cells CCR4-CCR6+ cells CCR4+CCR6+ cells
Percentage of IFNg+ cells 21.7 ± 8.4 13.1 ± 2.0 30.7 ± 1.1 6.0 ± 0.5
Percentage of IL-4+ cells 1.0 ± 0.3 5.4 ± 1.0a 1.5 ± 0.4 2.2 ± 0.6
Percentage of IL-17+ cells 0.1 ± 0.0 0.2 ± 0.0 9.1 ± 1.0a 9.7 ± 1.8a
Percentage of IL-22+ cells 0.1 ± 0.0 0.4 ± 0.2 3.3 ± 0.9a 5.0 ± 2.1a
Percentages of positive cells were assessed by flow cytometry. Values are expressed as mean ± standard error of the mean. aP < 0.5, bP < 0.01, Mann-Whitney U
test. CCR, CC chemokine receptor; IFNg, interferon-gamma; IL, interleukin.
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investigate the extent to which CCR4 and CCR6 expres-
sion could be implicated in T-cell recruitment in GPA,
we analyzed the expression of these chemokine recep-
tors on T cells.
In this study, we found increased frequencies of circu-
lating CCR4+ and CCR6+ cells within the total CD4+ T
cell population in GPA. In contrast, we found no signifi-
cant increase in the frequencies of CCR4+ and CCR6+
cells in the total CD8+ T cell population. CCR4 and
CCR6 expression suggests T cell activation [11,12]. Per-
sistent T cell activation regardless of clinical disease
activity has been reported in GPA [20,21,25]. Recently,
stable CCR6 expression was reported to be controlled
by epigenetic mechanisms [26]. In line with previous
reports, CCR4 and CCR6 expression was confined lar-
gely to circulating CCR7+CD45RA- central memory
(TCM), CCR7
-CD45RA- (TEM), and CCR7
-CD45RA+
(TEMRA) effector memory CD4
+ T cells [11,12]. We
found a significant increase in the frequency of CCR4+
and CCR6+ TEMRA and CCR6
+ TCM in patients with
GPA. Surprisingly, CCR4+ and CCR6+ cells were also
detected within the CCR7+CD45RA+ population, which
contains the naïve T cell subset (TN) by definition. TN
are CD45RA+ and express CCR7 for peripheral lymph
node homing but lack receptors such as CCR4 and
CCR6 for the migration to peripheral tissues [2,16-18].
Further analysis dissecting the CCR7+CD45RA+ popula-
tion with regard to CD45RA fluorescence intensity dis-
closed that the CCR7+CD45RA+ T-cell compartment
contained two subsets. One subset of CCR7+CD45RA-
high T cells generally lacked CCR4 and CCR6 expression
with the exception of three patients with GPA. Thus,
CCR7+CD45RAhigh T cells represented genuine TN.
CCR4 and CCR6 expression on CCR7+CD45RAhigh TN
in individual patients with GPA could represent TN acti-
vation, which has been reported before by demonstrat-
ing an increased frequency of CD4+CD45RO-FoxP3- TN
expressing the activation marker CD25 [20,25]. In line
with earlier studies, we showed that the percentage of
CCR7+CD45RAhigh TN within the total CD4
+ T cell
population was significantly lower in patients with GPA
[20,21]. In contrast, the percentage of CCR7
+CD45RAmed T cells was not decreased in patients with
GPA. CCR7+CD45RAmed T cells displayed CCR4 and
CCR6 expression reminiscent of so-called very early
memory T cells (TVEM). Higher frequencies of CCR4
+
and CCR6+ cells within the CCR7+CD45RAmed TVEM
subset were found in patients with GPA compared with
healthy controls. TVEM have been described earlier as
‘apparently TN’ oddly displaying chemokine receptors
for both lymph node homing (CCR7) and peripheral tis-
sue migration (CCR4 and CXCR3) in healthy individuals
by Song and colleagues [19]. Analysis of the prolifera-
tion history, T-cell receptor repertoire, and cytokine
response of CCR4- and CXCR3-expressing CCR7
+CD45RO- T cells suggests that these cells represent
TVEM, which have proceeded only a short way along the
differentiation pathway from TN to TCM or TEM. TVEM
are still multifunctional but finally differentiate into
either TCM or TEM [19].
Earlier studies showed that chemokine receptor expres-
sion for lymph node homing (CCR7) and peripheral tissue
migration (for example, CCR4) is not mutually exclusive
on T cell subsets [27]. The migratory behavior of TEM dis-
playing dual-chemokine receptor expression is determined
by chemotactic gradients and cytokine- and T-cell recep-
tor (TCR)-mediated signals [28]. CCR4-expressing CCR7+
TEM have been reported in inflamed peripheral tissues (for
example, in psoriasis and juvenile idiopathic arthritis)
[29,30]. Whereas CCR7- TEM remain in the peripheral tis-
sue, CCR7+ TEM migrate to peripheral tissues and subse-
quently exit the tissue to enter draining lymph nodes in
different animal models [31,32]. Although CCR7+ TEM
retain a capability to enter lymph nodes, inflammatory
cytokines can subvert migration of CCR7+ TEM, resulting
in the retention of CCR7+ TEM in the inflamed synovial
tissue [33]. Cytokines also drive the differentiation of
CCR4-expressing CCR7+ TCM to CCR7
- TEM [22]. Of
note, CCR7+ TEM accumulate in areas of ectopic lymphoid
tissue in the inflamed synovial tissue [30]. In contrast,
CCR4-expressing CCR7+ TVEM reside or recirculate in
secondary lymphoid tissues, where they continue to differ-
entiate and acquire further chemokine receptors for per-
ipheral tissue migration [19].
Having shown increased frequencies of circulating
CCR4- and CCR6-expressing CD4+ memory T cell sub-
sets, including TVEM in patients with GPA, we analyzed
the cytokine production of CCR4+ and CCR6+ T cells.
Previously, cloned and, as such, preselected CCR6+ cells
were reported to secrete IL-17, whereas CCR4+ T cells
produce IL-4 [11,12]. In our study, we found an
increased percentage of IL-17- and IL-22-producing
cells in the CCR4-CCR6+ ’single positive’ and CCR4
+CCR6+ ’double positive’ cell subsets and an increased
frequency of IL-4+ cells in the CRR4+CCR6- ’single posi-
tive’ cell subset compared with the CCR4-CCR6- ’double
negative’ cell subset within the total circulating CD4+ T-
cell population. Thus, in line with earlier studies, we
found Th17 cells within circulating CCR6+ cells and
Th2-type cells among CCR4+ cells [11,12]. Moreover,
CCR4-CCR6+ ’single positive’ and CCR4+CCR6+ ’double
positive’ cells differed from each other with respect to
the percentage of IFNg-producing cells, which was
higher in the former cell population.
Conclusions
We found increased frequencies of circulating CCR4+
and CCR6+ T cells in patients with GPA. CCR4 and
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CCR6 expression was confined largely to central mem-
ory (TCM) and effector memory (TEM and TEMRA) sub-
sets but could also be detected on very early memory T
cells (TVEM) displaying chemokine receptors for both
lymph node homing (CCR7) and peripheral tissue
migration (CCR4 and CCR6). CD4+CCR4+ and CD4
+CCR6+ T-cell populations contained distinct cytokine-
producing subsets. Our data suggest that CCR4 and
CCR6 could be involved in the recruitment of different
T cell subsets, including cytokine-producing cells, to
inflamed sites in patients with GPA. Further studies are
needed to assess CCR4+ and CCR6+ T cell reactivity to
the respective chemokine gradients and the expression
of CCR4, CCR6, and their chemokine ligands in inflam-
matory lesions in patients with GPA in order to define
new targets for therapeutic intervention.
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